Comparative 1-Year Outcomes of Invasive Staphylococcus aureus Infections Among Persons With and Without Drug Use: An Observational Cohort Study. (27th April 2021)

• Record Type: Journal Article
• Authors: Appa, Ayesha; Adamo, Meredith; Le, Stephenie; Davis, Jennifer; Winston, Lisa; Doernberg, Sarah B; Chambers, Henry; Martin, Marlene; Hills, Nancy K; Coffin, Phillip O; Jain, Vivek
• Is Part Of: Clinical infectious diseases. Volume 74:Number 2(2022)
• Page Start: 263
• Page End: 270
• Publication Date: 2021-04-27
• Subjects: Staphylococcus aureus -- methicillin-resistant Staphylococcus aureus -- bacteremia -- substance-related disorders -- patient readmission; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciab367
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: Persons who use drugs (PWUD) face substantial risk of Staphylococcus aureus infections. Limited data exist describing clinical and substance use characteristics of PWUD with invasive S. aureus infections or comparing treatment and mortality outcomes in PWUD vs non-PWUD. These are needed to inform optimal care for this marginalized population. Methods: We identified adults hospitalized from 2013 to 2018 at 2 medical centers in San Francisco with S. aureus bacteremia or International Classification of Diseases –coded diagnoses of endocarditis, epidural abscess, or vertebral osteomyelitis with compatible culture. In addition to demographic and clinical characteristic comparison, we constructed multivariate Cox proportional hazards models for 1-year infection-related readmission and mortality, adjusted for age, race/ethnicity, housing, comorbidities, and methicillin-resistant S. aureus (MRSA). Results: Of 963 hospitalizations for S. aureus infections in 946 patients, 372 of 963 (39%) occurred in PWUD. Among PWUD, heroin (198/372 [53%]) and methamphetamine use (185/372 [50%]) were common. Among 214 individuals using opioids, 98 of 214 (46%) did not receive methadone or buprenorphine. PWUD had lower antibiotic completion than non-PWUD (70% vs 87%; P < .001). While drug use was not associated with increased mortality, 1-year readmission for ongoing or recurrent infection was double in PWUD vs non-PWUD (28% vs 14%; adjusted hazard ratio [aHR], 2.0 [95% confidence interval {CI}: 1.3–2.9]). MRSA was independently associated with 1-year readmission for infection (aHR, 1.5 [95% CI: 1.1–2.2]). Conclusions: Compared to non-PWUD, PWUD with invasive S. aureus infections had lower rates of antibiotic completion and twice the risk of infection persistence/recurrence at 1 year. Among PWUD, both opioid and stimulant use were common. Models for combined treatment of substance use disorders and infections, particularly MRSA, are needed. Abstract : Persons who use drugs (PWUD) with invasive Staphylococcus aureus infections had lower rates of antibiotic completion and twice the risk of 1-year infection persistence/recurrence compared to non-PWUD. Methicillin-resistant S. aureus was also associated with 1-year infection readmission.